AXIM Biotechnologies, Inc. (AXIM)

AXIM Biotechnologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	0.04	0.01	0.06	0	0.8
Revenue Growth (YoY)	345.27%	-85.32%	-	-	308.70%
Cost of Revenue	0.43	0.43	0	0.02	0.58
Gross Profit	-0.39	-0.42	0.06	-0.02	0.22
Selling, General & Admin	2.24	4.08	5.67	4.51	4.27
Research & Development	0.13	0.15	0.28	0.43	2.45
Other Operating Expenses	-0.08	0.43	1.84	-0.1	0
Operating Expenses	2.36	4.66	7.79	4.83	6.73
Operating Income	-2.75	-4.65	-7.99	-4.95	-6.51
Interest Income	0	0	0	0	0.3
Interest Expense	1.2	1.88	0.49	0.32	0.32
Other Expense / Income	4.1	-0.29	7.55	1.02	-0.08
Pretax Income	-8.06	-6.24	-16.02	-6.29	-6.45
Income Tax	0	-0.29	0.49	0.44	0.32
Net Income	-8.06	-5.96	-16.52	-6.73	-6.77
Shares Outstanding (Basic)	228	165	132	110	62
Shares Outstanding (Diluted)	228	165	132	110	62
Shares Change	37.60%	25.79%	19.16%	78.19%	8.14%
EPS (Basic)	-0.04	-0.04	-0.13	-0.06	-0.11
EPS (Diluted)	-0.04	-0.04	-0.13	-0.06	-0.11
Free Cash Flow	-1.03	-2.05	-2.54	-3.31	-5.02
Free Cash Flow Per Share	-0.00	-0.01	-0.02	-0.03	-0.08
Gross Margin	-980.57%	-4701.42%	100.00%	-	27.99%
Operating Margin	-6960.98%	-52425.60%	-13207.09%	-	-813.73%
Profit Margin	-20394.96%	-67120.74%	-27320.76%	-	-846.98%
Free Cash Flow Margin	-2607.67%	-23132.80%	-4196.59%	-	-627.92%
EBITDA	-2.32	-4.23	-5.87	-4.82	-6.5
EBITDA Margin	-5880.41%	-47621.28%	-9707.77%	-	-812.92%
Depreciation & Amortization	0.43	0.43	2.12	0.02	0.01
EBIT	-2.75	-4.65	-7.99	-4.83	-6.51
EBIT Margin	-6960.98%	-52422.70%	-13207.09%	-	-813.73%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.